Press release
Sickle Cell Disease Treatment Market Research Reveals Path To $7.98 Billion By 2030
Sickle Cell Disease Treatment Market
Projected Market Size and Growth of the Sickle Cell Disease Treatment Market
The sickle cell disease treatment market is anticipated to experience rapid expansion, reaching a valuation of $7.99 billion by 2030. This growth corresponds to an impressive compound annual growth rate (CAGR) of 18.1%. Key drivers behind this surge include the rise of gene therapy innovations, a growing portfolio of biologic and targeted medications, the integration of predictive diagnostics, increased global health initiatives, and the shift toward personalized treatment approaches tailored to individual patient needs. Emerging trends shaping this market involve advances in gene-editing technologies, wider availability of hydroxyurea, expanded use of blood transfusion management, adoption of sophisticated diagnostic methods for early disease detection, and enhanced patient support and disease management programs.
The sickle cell disease treatment market size has grown rapidly in recent years. It will grow from $3.51 billion in 2025 to $4.11 billion in 2026 at a compound annual growth rate (CAGR) of 17.3%. The growth in the historic period can be attributed to high prevalence in Africa and Americas, limited treatment availability, reliance on blood transfusions, growth in hematology research, lack of early diagnostic awareness.
Download a free sample of the sickle cell disease treatment market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13048&type=smp&utm_source=OpenPR&utm_medium=Paid&utm_campaign=Aug_PR
Leading Corporations Steering the Sickle Cell Disease Treatment Industry
Several prominent pharmaceutical and biotech companies dominate the sickle cell disease treatment arena. Notable players include Sun Pharmaceutical Industries Ltd., Pfizer Inc., Johnson & Johnson Private Limited, Merck & Co Inc., Novartis AG, Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca plc, Eli Lilly and Company, Gilead Sciences Inc., Amgen Inc., Baxter International Inc., Teva Pharmaceutical Industries Ltd., Vertex Pharmaceuticals Incorporated, Global Blood Therapeutics Inc., Acceleron Pharma Inc., Sangamo Therapeutics Inc., Medunik USA Inc., Zydus Cadila Healthcare Ltd., Graphite Bio Inc., Addmedica, Emmaus Medical Inc., Bluebird bio Inc., CRISPR Therapeutics AG, GlycoMimetics Inc., and Mast Therapeutics Inc.
Noteworthy Collaborations Advancing Gene Therapy Efforts
In December 2023, Vertex Pharmaceuticals, based in the United States, formed a partnership with Editas Medicine to leverage Editas's Cas9 gene-editing technology. This collaboration aims to accelerate the development of ex vivo gene therapies, such as CASGEVY, targeting sickle cell disease and beta thalassemia. Editas Medicine specializes in CRISPR/Cas9 and Cas12a genome editing platforms designed for therapeutic applications, marking a significant step forward in precision gene therapy pipelines for these hemoglobin disorders.
View the full sickle cell disease treatment market report:
https://www.thebusinessresearchcompany.com/report/sickle-cell-disease-treatment-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Aug_PR
Emerging Focus on Oral Suspension Medications for Better Patient Experience
A key trend in the sickle cell disease treatment market is the drive by companies to develop novel oral suspension drugs. These formulations aim to improve patient adherence, enhance drug effectiveness, and offer easier dosing options, particularly for children and elderly patients who may struggle with traditional pills. For example, in March 2024, Akums Drugs and Pharmaceuticals Ltd., an India-based pharmaceutical manufacturer, introduced a room temperature-stable oral suspension of Hydroxyurea. This affordable treatment is tailored to increase accessibility in India, costing less than 1% of imported alternatives. It provides accurate dosing via oral syringes and does not require refrigeration, making it suitable for patients across all age groups.
Detailed Segmentation of the Global Sickle Cell Disease Treatment Market
This market report segments the sickle cell disease treatment industry into several key categories for a comprehensive analysis:
1) Treatment Modality: including Blood Transfusion, Pharmacotherapy, and Bone Marrow Transplant
2) Disease Type: covering Sickle Cell Anemia, Hemoglobin Sickle C Disease (HbSC), and other related types
3) Route of Administration: divided into Oral and Parenteral methods
4) End-User: encompassing Hospitals, Specialty Clinics, and other healthcare settings
Further subcategories include:
- Blood Transfusion: Regular Blood Transfusion and Exchange Transfusion
- Pharmacotherapy: Hydroxyurea, L-Glutamine, Voxelotor, Crizanlizumab
- Bone Marrow Transplant: Allogeneic Transplant and Autologous Transplant
This segmentation offers detailed insights into treatment options and patient demographics, highlighting the diverse approaches to managing sickle cell disease globally.
The 2026 edition of our market reports now delivers enhanced analytical coverage through market attractiveness scoring and analysis, total addressable market (TAM) analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, key technologies and future trend analysis, plus updated graphics and tables.
Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Sickle Cell Disease Treatment Market Research Reveals Path To $7.98 Billion By 2030 here
News-ID: 4614064 • Views: …
More Releases from The Business Research Company
Revenue Cycle Management Software Market Intelligence Report Covers Trends, Segm …
The healthcare industry is undergoing significant transformation, with technological innovations playing a key role in streamlining administrative processes. One such critical area witnessing rapid advancements is revenue cycle management software, which is pivotal for improving financial operations in healthcare settings. Let's delve into the current market scope, influential players, emerging trends, and segment dynamics shaping this vital software sector.
Revenue Cycle Management Software Market Size and Projected Growth by 2030 …
Retinoblastoma Treatment Market Trends Support A 4.9% CAGR Outlook Through The F …
Understanding the future outlook of retinoblastoma treatment reveals promising advancements fueled by ongoing research and innovation. This sector is witnessing steady progress as new therapies emerge, and collaborative efforts between global organizations intensify to improve patient outcomes worldwide.
Retinoblastoma Treatment Market Size and Growth Projections
The retinoblastoma treatment market is on track for consistent expansion, anticipated to reach a value of $2.75 billion by 2030. This growth corresponds to a…
Retinal Vein Occlusion Market Report Examines Industry Trends, Growth Drivers An …
The retinal vein occlusion market is on the brink of substantial expansion, driven by advances in treatment and diagnostic technologies. As the demand for more personalized and less invasive care grows, the sector is set to experience significant developments through 2030. Let's explore the expected market size, key players, emerging trends, and how the market is segmented to better understand the landscape ahead.
Projected Market Size and Growth Rate of the…
Retail Clinics Market Report Examines Leading Companies And Growth Opportunities
The retail clinics sector is rapidly evolving as healthcare delivery adapts to new technologies and patient preferences. Increasing demand for accessible, affordable care outside traditional settings is driving expansion in this market. Let's explore the projected growth, key players, emerging trends, and important segments shaping the retail clinics industry.
Forecasted Growth Trajectory of the Retail Clinics Market
The retail clinics market is set to experience significant expansion in the coming…
More Releases for Sickle
Sickle Cell Disease Treatment Market - Improving Quality of Life: Pioneering Sic …
Newark, New Castle, USA: The "Sickle Cell Disease Treatment Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors
Sickle Cell Disease Treatment Market: https://www.growthplusreports.com/report/sickle-cell-disease-treatment-market/7808
This latest report researches the…
Sickle Cell Disease Treatment Market - Breaking the Chains of Sickle Cell: Pione …
Newark, New Castle, USA - new report, titled Sickle Cell Disease Treatment Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Sickle Cell Disease Treatment market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Sickle Cell Disease Treatment market. The report offers…
Global Sickle Cell Disease Treatment Market 2023: Sickle Cell Anaemia Anticipate …
The sickle cell disease treatment market is a segment of the broader pharmaceutical industry that is focused on developing treatments for sickle cell disease, a genetic disorder that affects the red blood cells. In 2022, the sickle cell disease treatment market is expected to continue to grow, driven by the increasing prevalence of the disease and the development of new treatments. The market is expected to be worth billions of…
Global Sickle Cell Disease Treatment Market 2023: Sickle Cell Anaemia Anticipate …
The sickle cell disease treatment market refers to the segment of the healthcare industry that produces and markets treatments for sickle cell disease (SCD), a genetic disorder that affects the production of hemoglobin in red blood cells. SCD can cause various complications, including pain, infections, and organ damage, and there is currently no cure for the disease. However, various treatments are available that can help manage the symptoms and improve…
Global Sickle Cell Disease Treatment Market 2023: Sickle Cell Anaemia Anticipate …
The sickle cell disease treatment market refers to the segment of the pharmaceuticals industry that deals with the production and sales of treatments for sickle cell disease. Sickle cell disease is a genetic blood disorder that causes red blood cells to become misshapen and form a sickle shape. This can lead to a range of complications, including anemia, chronic pain, and increased risk of infections.
The market for sickle cell disease…
Global Sickle Cell Disease Treatment Market 2023: Sickle Cell Anaemia Anticipate …
The Sickle Cell Disease Treatment Market is an emerging segment in the healthcare industry. This debilitating disorder affects millions of people around the world, with no known cure available. However, recent advances in research have improved the treatment options for those suffering from sickle cell disease. The Sickle Cell Disease Treatment Market is expected to experience significant growth over the coming years as treatments become more effective and accessible. Several…
